Avantor (NYSE:AVTR) Price Target Cut to $25.00 by Analysts at Barclays

Avantor (NYSE:AVTR) had its price objective cut by Barclays from $28.00 to $25.00 in a report published on Friday, Benzinga reports. They currently have an overweight rating on the stock.

A number of other equities research analysts have also issued reports on the company. Evercore ISI increased their price target on Avantor from $26.00 to $28.00 and gave the stock an outperform rating in a research note on Thursday, April 4th. Robert W. Baird decreased their target price on Avantor from $27.00 to $26.00 and set an outperform rating on the stock in a research note on Monday, April 29th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Avantor from $23.00 to $25.00 and gave the stock a hold rating in a research note on Thursday, April 18th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of Moderate Buy and a consensus price target of $26.36.

Avantor Stock Down 1.1 %

AVTR stock opened at $21.20 on Friday. The business’s 50-day moving average price is $23.73 and its 200-day moving average price is $23.79. The stock has a market cap of $14.40 billion, a P/E ratio of 54.35, a PEG ratio of 2.23 and a beta of 1.35. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 0.94. Avantor has a twelve month low of $16.63 and a twelve month high of $26.16.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.02. The business had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.68 billion. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The company’s revenue for the quarter was down 5.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.29 earnings per share. On average, equities research analysts forecast that Avantor will post 1.01 EPS for the current year.

Institutional Investors Weigh In On Avantor

Several large investors have recently added to or reduced their stakes in AVTR. Fifth Third Bancorp boosted its holdings in shares of Avantor by 125.3% in the 4th quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock worth $28,000 after purchasing an additional 694 shares during the period. Livforsakringsbolaget Skandia Omsesidigt lifted its position in Avantor by 565.5% in the fourth quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock worth $30,000 after buying an additional 1,131 shares during the last quarter. Gladius Capital Management LP purchased a new position in Avantor during the fourth quarter worth $42,000. Montag A & Associates Inc. bought a new position in Avantor during the fourth quarter valued at $43,000. Finally, TFO Wealth Partners LLC raised its stake in shares of Avantor by 203,100.0% in the fourth quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock valued at $46,000 after acquiring an additional 2,031 shares during the period. 95.08% of the stock is owned by institutional investors.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.